Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Euroapi S.A. operates in the pharmaceutical industry, specializing in the development, production, and marketing of active pharmaceutical ingredients (APIs). The company provides an extensive range of complex chemical molecules, including pain management and anesthetics, anti-infectives, and endocrine therapy solutions. Headquartered in Paris, France, Euroapi serves global markets, emphasizing high standards in quality and compliance. The company leverages long-standing expertise and technical capabilities, distinguishing itself with a broad product portfolio and investment in research and development to support innovation and meet diverse customer needs.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Euroapi S.A.Johnson & Johnson
Last price
€0.78$283.52
Currency
EUR
USD
€74M$675B
-42.59
-€3.43$6.58
0.960.21
0$5.28
01.91%
Sector
HealthHealth
Employees
2,961138,200
Ticker
€EAPI$JNJ
Primary listing
PARNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €EAPI or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.